Matinas BioPharma Files 8-K for Bylaws and Financials
Ticker: MTNB · Form: 8-K · Filed: Aug 6, 2025 · CIK: 1582554
| Field | Detail |
|---|---|
| Company | Matinas Biopharma Holdings, Inc. (MTNB) |
| Form Type | 8-K |
| Filed Date | Aug 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, financial-reporting
TL;DR
Matinas BioPharma filed an 8-K for corporate housekeeping and financials. No major news.
AI Summary
Matinas BioPharma Holdings, Inc. filed an 8-K on August 6, 2025, reporting amendments to its articles of incorporation or bylaws and financial statements. The filing does not contain specific financial figures or details about the amendments.
Why It Matters
This filing indicates routine corporate actions and the submission of financial information, which are standard for public companies and provide transparency to investors.
Risk Assessment
Risk Level: low — The filing appears to be routine administrative and financial reporting, with no immediate indication of significant operational or financial changes.
Key Players & Entities
- Matinas BioPharma Holdings, Inc. (company) — Registrant
- August 6, 2025 (date) — Date of earliest event reported
FAQ
What specific amendments were made to Matinas BioPharma's articles of incorporation or bylaws?
The filing indicates that amendments were made, but the specific details of these amendments are not provided in the summary information.
What is the nature of the financial statements being filed?
The filing states that financial statements are being filed, but the type or period covered by these statements is not specified in the provided text.
Is there any information regarding a change in Matinas BioPharma's fiscal year?
The filing lists 'Change in Fiscal Year' as an item information, but does not specify if a change occurred or what the new fiscal year end might be.
What is the principal executive office address for Matinas BioPharma?
The principal executive offices are located at 1545 Route 206 South, Suite 302, Bedminster, New Jersey 07921.
What is the telephone number for Matinas BioPharma?
The registrant's telephone number, including area code, is (908) 484-8805.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 6, 2025 regarding Matinas BioPharma Holdings, Inc. (MTNB).